Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Capital Leases (2016 - 2018)

Historic Capital Leases for Accendra Health (ACH) over the last 6 years, with Q4 2018 value amounting to $14.2 million.

  • Accendra Health's Capital Leases fell 3198.01% to $14.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $14.2 million, marking a year-over-year decrease of 3198.01%. This contributed to the annual value of $14.2 million for FY2018, which is 3198.01% down from last year.
  • Accendra Health's Capital Leases amounted to $14.2 million in Q4 2018, which was down 3198.01% from $20.9 million recorded in Q4 2017.
  • Over the past 5 years, Accendra Health's Capital Leases peaked at $29.5 million during Q4 2015, and registered a low of $14.2 million during Q4 2018.
  • Its 4-year average for Capital Leases is $22.3 million, with a median of $22.7 million in 2016.
  • In the last 5 years, Accendra Health's Capital Leases crashed by 1491.3% in 2017 and then tumbled by 3198.01% in 2018.
  • Over the past 4 years, Accendra Health's Capital Leases (Quarter) stood at $29.5 million in 2015, then fell by 16.89% to $24.5 million in 2016, then dropped by 14.91% to $20.9 million in 2017, then tumbled by 31.98% to $14.2 million in 2018.
  • Its Capital Leases stands at $14.2 million for Q4 2018, versus $20.9 million for Q4 2017 and $24.5 million for Q4 2016.